DJIA 16,514.37 0.00 0.00%
NASDAQ 4,161.46 0.00 0.00%
S&P 500 1,879.55 0.00 0.00%
market minute promo

311.68 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $311.68 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $302.76
Previous Close $311.68
Daily Range $302.15 - $313.50
52-Week Range $206.30 - $352.49
Market Cap $31.1B
P/E Ratio 79.27
Dividend (Yield) $0.00 (0.0%)
Volume 736,072
Average Daily Volume 1,156,220
Current FY EPS $4.38

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

3 Stocks Reiterated As A Hold: PM, FSLR, REGN

Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner

Nasdaq 100 Movers: LLTC, YHOO

UPDATE: Canaccord Genuity Initiates Coverage on Regeneron Pharmaceuticals on Expected Continued Pipe

UPDATE: Canaccord Genuity Initiates Coverage on Regeneron Pharmaceuticals on Expected Continued Pipeline Success

3 Stocks Reiterated As A Hold: TSLA, PM, REGN

New Stock Coverage: Use (Don't Lose) Your Head in Regeneron

Wall Street ratings agencies set the tone for today's stock market.

Benzinga's Top Initiations

Good News for BioMarin - Analyst Blog

See More REGN News...

REGN's Top Competitors

REGN $311.68 (0.00%)
Current stock: REGN
AMGN $119.30 (0.00%)
Current stock: AMGN
GILD $72.86 (0.00%)
Current stock: GILD
BIIB $306.20 (0.00%)
Current stock: BIIB